Claudin-1 as a novel target gene induced in obesity and associated to inflammation, fibrosis and cell differentiation.
Obesity
claudin
immunometabolism
lymphocytes
Journal
European journal of endocrinology
ISSN: 1479-683X
Titre abrégé: Eur J Endocrinol
Pays: England
ID NLM: 9423848
Informations de publication
Date de publication:
20 Feb 2024
20 Feb 2024
Historique:
received:
07
09
2023
revised:
26
01
2024
accepted:
06
02
2024
medline:
20
2
2024
pubmed:
20
2
2024
entrez:
20
2
2024
Statut:
aheadofprint
Résumé
T-lymphocytes from visceral and subcutaneous white adipose tissue (vWAT and sWAT, respectively) can have opposing roles in the systemic metabolic changes associated with obesity. However, few studies have focused on this subject. Claudin-1 (CLDN1) is a protein involved canonically in Tight Junctions (TJs) and tissue paracellular permeability.We evaluated T lymphocytes gene expression in vWAT and sWAT and in the whole adipose depots in human samples. A Clariom D-based transcriptomics analysis was performed on T lymphocytes magnetically separated from vWAT and sWAT from patients with obesity (Cohort 1; N = 11). Expression of candidate genes resulting from that analysis was determined in whole WAT from individuals with and without obesity (Cohort 2; Patients with obesity: N = 13; Patients without obesity: N=14). We observed transcriptional differences between T lymphocytes from sWAT compared to vWAT. Specifically, CLDN1 expression was found to be dramatically induced in vWAT T cells relative to those isolated from sWAT in patients with obesity. CLDN1 was also induced in obesity in vWAT and its expression correlates with genes involved in inflammation, fibrosis and adipogenesis. These results suggest CLDN1 is a novel marker induced in obesity, and differentially expressed in T lymphocytes infiltrated in human vWAT as compared to sWAT. This protein may have a crucial role in the crosstalk between T lymphocytes and other adipose tissue cells and may contribute to inflammation, fibrosis and alter homeostasis and promote metabolic disease in obesity.
Identifiants
pubmed: 38375549
pii: 7610964
doi: 10.1093/ejendo/lvae018
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© The Author(s) 2024. Published by Oxford University Press on behalf of European Society of Endocrinology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.